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Abstract
Prohibitin 1 (PHB1) is a highly conserved protein that together with its homologue prohibitin 2 (PHB2) mainly localizes to
the inner mitochondrial membrane. Although it was originally identified by its ability to inhibit G1/S progression in human
fibroblasts, its role as tumor suppressor is debated. To determine the function of prohibitins in maintaining cell homeostasis,
we generated cancer cell lines expressing prohibitin-directed shRNAs. We show that prohibitin proteins are necessary for
the proliferation of cancer cells. Down-regulation of prohibitin expression drastically reduced the rate of cell division.
Furthermore, mitochondrial morphology was not affected, but loss of prohibitins did lead to the degradation of the fusion
protein OPA1 and, in certain cancer cell lines, to a reduced capability to exhibit anchorage-independent growth. These
cancer cells also exhibited reduced adhesion to the extracellular matrix. Taken together, these observations suggest
prohibitins play a crucial role in adhesion processes in the cell and thereby sustaining cancer cell propagation and survival.
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Introduction
Prohibitins (PHB1 and PHB2) are highly homologous proteins
that are conserved throughout evolution and ubiquitously
expressed [1–3]. Prohibitins mainly localize to the mitochondria
but are also found in the nucleus and in lipid rafts of the
cytoplasmic membrane [1,4–7]. Localization to lipid rafts is also a
feature of other members of the stomatin/prohibitin/flotilin/
HflK/C-domain (SPFH) family of proteins [8].
Studies to date have associated PHB1 with diverse roles in the
maintenance of cellular homeostasis. Initial work suggested it
functions as an inhibitor of DNA synthesis, a role which was later
assigned to its 39UTR [9,10]. A T-allelic expression form of PHB1
was associated with an increased risk of breast cancer [11]; however
this association was not confirmed in a clinical setting [12,13]. PHB1
co-localizes with transcription factors of the E2F family in the nucleus
of breast carcinoma cells [14], and interacts with the Rb tumor
suppressor protein pRB in the nucleus resulting in inhibition of the
cell cycle [15]. Correspondingly, siRNA-mediated silencing of PHB1
expression was found to increase breast cancer cell proliferation [16].
Despite these indications of a tumor suppressor activity, recent studies
have also demonstrated reduced cell proliferation upon loss of PHB1
expression in mouse embryonic fibroblasts and other primary cells;
and the rescue of cell proliferation upon overexpression of
mitochondrial-targeted PHB2 [17].
Our recent work indicates PHB1 also plays a role in cell
migration: Transient silencing of PHB1 by siRNA-mediated
knockdown led to a clumping phenotype in HeLa cells, comparable
to that of a Her2/ErbB2 or Rac defect, i.e. clumped cells showed
marked membrane staining for pan-cadherin and b-catenin. The
authors suggested contact between cells were disrupted in tumor
cells due to the loss of PHB1 [6]. Studies in yeast have consistently
shown that PHB1 and PHB2 act as mitochondrial chaperones in the
inner mitochondrial membrane [3,18–20]. PHB1 and PHB2 are
interdependent on the protein level and loss of one simultaneously
leads to the loss of the other [21]. They interact with mitochondrial
proteases, particularly mAAA, which is required in the assembly of
respiratory chain complexes [22,23]. A knock-out of prohibitins in
yeast led to a reduced replicative lifespan and a defect in
mitochondrial membrane potential [18,24]. Several recent studies
have also addressed the mitochondrial function of prohibitins in
human cell lines: Overexpression of PHB1 was found to protect
against oxidative stress [25]; in addition, siRNA-mediated knock-
down of PHB2 led to the degradation of the mitochondrial fusion
protein OPA1 [17] and fragmentation of the mitochondrial network
[21]. However, it is still not clear whether prohibitin expression
stabilizes the mitochondrial membrane potential (MMP) [17,26,27].
Here we show prohibitins play a role in maintaining cellular
homoeostasis and proliferation in cancer cells and primary cells.
Depletion of prohibitins had no major effect on mitochondrial
function but did affect adhesion of cells to the extracellular matrix.
Materials and Methods
Cell culture
HEK293 and HeLa cells were obtained from German Collection
of Microorganisms and Cell Cultures (DSMZ). HT1080wt, Jurkat
and CapanI cells were obtained from American Type Culture
Collection (ATCC). IF6 cells were a gift from U. Rapp, Wu¨rzburg.
HeLa cells were tested and authenticated by DSMZ via STR-
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fingerprinting. HEK293 cells and HT1080wt cells were cultured in
DMEM with 10% FCS, 1% Penicillin/Streptomycin, 10 mM
HEPES pH 7.4 and 4 mM L-Glutamine. HeLa cells, IF6 cells and
Jurkat cells were cultured in RPMI with 10% FCS, 1% Penicillin/
Streptomycin. HT29 cells were cultured in McCoy’s medium,
supplemented with 10% FCS and 1% Penicillin/Streptomycin.
Capan I cells were cultured in RPMI with 20% FCS and 1%
Penicillin/Streptomycin. All cells were cultured at 37uC with 5%
CO2.
Generation of shRNA knockdown cell lines
shRNA-expressing vectors were constructed by cloning different
shRNAs into the pLL3.7 or pLVTHM vector. To generate an
inducible vector system, the shRNAs from the constitutive expression
system pLVTHM were subcloned into the inducible vector system
pLVPT, by transferring the cassette containing the shRNA and the
H1 promoter via the XhoI/XbaI restriction sites. All constructs were
verified by sequencing. Nucleotide sequences of shRNA targets used
are as follows: shLuci, 59-AACTTACGCTGAGTACTTCGA-39;
PHB1-0, 59- GCGGAGAGAGCCAGATTTG-39; PHB1-3, 59-
GACACATCTGACCTTCGGGAA-39; and PHB2-0, 59-GACA-
GAGAGGGCCAAGGAC-39. Stably transduced, constitutive or
inducible knockdown cell lines were constructed as described
previously [28]; see also http://tronolab.epfl.ch/). Briefly, HeLa cells
were transduced with the respective lentiviral vector in the presence
of Polybrene (Sigma-Aldrich, St Louis, MO, USA). For the
transduction of pLVPT lentiviral vectors, shRNA expression was
induced by treatment with 1 mg/ml doxycycline (Sigma) for 3 days
and cells were sorted for eGFP expression with the MoFloH Flow
Cytometer (Dako Denmark A/S, Glostrup, Denmark). For validation
of the knockdown levels, RNA was isolated using the RNAeasy Kit
(Qiagen, Hilden, Germany). Quantitative real-time PCR was
performed with the QuantiTect SYBR Green real-time PCR Kit
(Qiagen) according to the manufacturer’s protocol. All vectors were
obtained fromD. Trono, Ecole Polytechnique Fe´de´rale de Lausanne,
France.
Soft agar assay
Cells (26103) were inoculated into 0.3% low melting temper-
ature agarose (Sigma) in DMEM supplemented with 10% FCS,
and colonies were counted after 2–4 weeks of incubation at 37uC
and 5% CO2.
Cell proliferation and cell cycle analysis
For CFSE staining, cells were harvested and washed two times
in PBS, then stained with 5 mM CFSE for 5 min at room
temperature (RT). Residual CFSE was removed by washing twice
with PBS and cells were seeded in 6-well plates and grown in cell
culture medium. The CFSE fluorescence intensity was measured
by FACS analysis every 24 hours for 5 days. BrdU assays were
performed using the Cell Proliferation ELISA, BrdU (chemiluminescent)
kit (Roche) according to the manufacturer’s instructions. Briefly,
cells were seeded at 3.56103 in a white rimmed 96-well plate.
BrdU was added to a final concentration of 10 mM for 1 hour.
Peroxidase conjugated anti-BrdU antibody was added to cells for
30 to 60 min at RT and luminescence was measured after an
incubation of 3 to 10 min using a Monolight 3096 microplate
luminometer (BD Bioscience).
TMRE staining
To analyze mitochondrial membrane potential, 100 nM
TMRE was added to culture medium and cells were further
incubated for 30 min under normal culture conditions. Incorpo-
ration was measured by FACS. To control for the complete loss of
membrane potential, 1 mM CCCP was added for 5 min.
ATP levels
Cellular ATP synthesis was measured using an ATP Biolumines-
cence Assay Kit HSII (ROCHE), according to the manufacturer’s
instructions. Briefly, 105 to 107 cells/25 ml per well of a 96 well
plate were lysed in the same volume of cell lysis reagent by
incubation for 5 min at RT. Fifty microlitres of the reconstituted
luciferase reagent was added to the well by automated injection
(BD Bioscience, Monolight luminometer). Measurements (dura-
tion of 2 seconds) were taken after a 1 second delay.
Western blotting
Cells were lysed in 2 x sample buffer containing 200 mM DTT
and proteins were separated using 10% SDS-PAGE. After
electrophoresis, the proteins were electrotransferred onto a
polyvinylidene fluoride microporous membrane and immunode-
tected using antibodies against OPA1 (BD Biosciences), PHB1 and
PHB2 (NeoMarkers) and Actin (Sigma). OPA1 fragmentation was
quantified using AIDA software.
Immunofluorescence staining
Cells grown on coverslips were fixed with 4% paraformadehyde
for 30 min at RT, and then permeabilized in 0.5% Triton X-100.
Next, cells were immunostained using the following antibodies:
mouse anti-Tom20 (BD Biosciences) (1:100 dilution, 2 h RT),
mouse anti-Paxillin-1 (BD Transduction) (1:100), phalloidin-alexa
488 (MoBiTec) (1:200) and donkey anti-mouse, CyTM3 (1:100).
Quantification of the mitochondrial network was done using
ImageJ software.
Transmission electron microscopy
Cells depleted of prohibitins by inducing shRNA expression for
10 days were fixed with 2.5% glutaraldehyde, postfixed with 0.5%
osmium tetroxide and contrasted using tannic acid and uranyl
acetate. Specimens were dehydrated in a graded ethanol series and
embedded in Polybed. Ultrathin sections were analysed in a Leo
906E transmission electron microscope (Leo GmbH).
Adhesion assay
To measure adhesion of cells, microplates were coated with
1 mg/ml fibronectin, 2 mg/ml collagen or 3 mg/ml BSA,
respectively. GFP expression was below the sensitivity of the
fluorometer (at 488 nm), therefore we stained cells with CFSE
prior to seeding. Cells were incubated on coated wells for 30 min
at 37uC.
To analyze cellular migration and adhesion, cells induced with
doxycycline for 8 days were seeded under subconfluent conditions,
in cell culture plates or coverslips, for 20 h followed by 4 h serum
starvation. The cells were treated with 50 mM Forskolin for
20 min to induce cAMP/PKA activation and thereby lamellipodia
and focal adhesion formation. Actin filaments and focal adhesions
were visualized via immunocytochemistry and focal adhesions
were counted manually.
Results
Selective loss of PHB1 depleted cells
To date no consensus on the function of PHB1 has been
reached; in breast cancer cells, PHB1 has been reported to act as a
tumor suppressor [15,16], whereas in primary endothelial cells
depletion of PHB1 resulted in reduced cell proliferation [26]. To
PHB Required for Proliferation
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define the role of PHB1 in HeLa cells, an adenocarcinoma cell
line, we generated stable cell lines expressing PHB1-directed
shRNAs using the constitutive pLL3.7 lentiviral shRNA expression
system [29]. Expression of three different shRNAs, shPHB1-2,
shPHB1-3 and shPHB1-0, targeting the coding region of PHB1
induced the depletion of PHB1 by RNA interference (RNAi) at the
mRNA (Fig. 1A) and protein (Fig. 1B) level. The depletion of
PHB1 correlated with the simultaneous expression of the marker
protein eGFP (Fig. 1C), indicating the successful lentiviral
transduction of these cells. We then grew the different cell lines
and monitored the composition of the cell population using
microscopy and FACS analysis. A selective reduction of shPHB-
expressing cells from the cell pool was observed, visible by a
reduction in the eGFP-positive cell population (Fig. 1D). This loss
was not due to increased apoptosis of the shRNA-expressing cells
(data not shown) but faster growth of non-transduced, PHB1
protein-expressing cells, and therefore eGFP-negative cells, which
showed normal proliferation.
To test whether this observation was specific for HeLa cells, a
number of different cancer cell lines, including Capan1 cells,
HT1080wt, Jurkat T cells, IF6 and HT29 cells, were transduced
with the same lentiviral shRNA construct and their growth
monitored as before. Western blot analysis revealed expression of
shPHB1-0 resulted in depletion of PHB1 in all cell lines tested (Fig.
Figure 1. Silencing of PHB1 led to a decrease in cell proliferation and anchorage-dependent growth in HeLa cells. (A, B) PHB1 mRNA
and protein levels were efficiently reduced in cells expressing shPHB1-0, shPHB1-2 and shPHB1-3 using the constitutive lentiviral expression system
pLL3.7 as was shown by qRT-PCR and Western Blots, respectively. (C) Upon lentiviral transduction stable integration is indicated by GFP expression.
(D) With the expression of positively validated shRNAs targeting PHB1 mRNA the fraction of GFP expressing cells was reduced within ten days of
transduction from a pool of transduced cells within, as shown by FACS analysis. (E) Transduced HeLa cells expressing control vector or PHB1 targeting
shRNAs were seeded in soft agar. Only control cells grew under anchorage-independent conditions and formed colonies.
doi:10.1371/journal.pone.0012735.g001
PHB Required for Proliferation
PLoS ONE | www.plosone.org 3 September 2010 | Volume 5 | Issue 9 | e12735
S1A). In addition, similar to HeLa cells, prolonged cultivation
resulted in a loss of eGFP-positive cells (Fig. S1B), ruling out a cell
line-specific effect. Interestingly, a similar phenomenon was
observed in proliferating primary human umbilical vein endothe-
lial cells (HUVEC) after transducing shPHB1-0 (data not shown),
suggesting that loss of PHB1 interferes with proliferation.
Since anchorage-independent growth is a hallmark of cancer
cells [30], we also assessed this phenotype in our cell lines
constitutively expressing shRNAs targeting PHB1. Cells were
seeded in soft agar and their growth monitored as before. Control
and non-transduced cells exhibited normal growth characteristics,
forming colonies and proliferating, whereas PHB1-knockdown
cells remained as single cells (Fig. 1E), indicating PHB1 plays a role
in anchorage-independent growth.
PHB1/PHB2 are required for proliferation of cancer cells
Since conditional silencing of PHB1 expression led to loss of
proliferation and consequently an overgrowth by untransduced
cells, long-term studies on the effects of reduced PHB1 expression at
the molecular level were not possible. Therefore, we expressed the
same validated shRNAs for the functional knockdown of PHB1 in a
lentiviral vector under the control of a doxycycline-inducible
promoter [28]. To analyze the role of PHB2 and its interaction
with PHB1, we designed an additional shRNA specifically targeting
PHB2 mRNA (for details see Materials and Methods).
Reductions in PHB1 and PHB2 protein expression were
observed 3 to 4 days after the addition of doxycycline, becoming
markedly reduced at 5–6 days and then remaining stably reduced
for up to 10 days (Fig. 2A, B). Depletion of one prohibitin protein
led to the loss of the other (Fig. 2C). This effect was probably due
to protein destabilization as mRNA levels of the non-silenced gene
remained constant (data not shown). As previously observed upon
constitutive silencing of PHB1 (Fig. 1D), inducible silencing of
prohibitins led to reduced proliferation of cells. BrdU incorpora-
tion assays revealed reduced DNA synthesis 5 days post induction
of PHB1 and PHB2 depletion (Fig. 2D). To assess the proliferation
rate at a single-cell level, cells were stained with Carboxy
fluorescent succinidylester (CFSE); this stain is evenly distributed
in the cytoplasm and stoichiometrically distributed to daughter
cells during cell division. Cell proliferation was clearly decreased in
PHB1- or PHB2-depleted cells in comparison to control cells
(Fig. 2E). Furthermore, these cells showed reduced anchorage
independence and failed to grow on soft agar (Fig. 2F). Thus, our
data demonstrates that prohibitins play a role in cell proliferation.
Loss of prohibitins leads to fragmentation of
mitochondria
Since prohibitins are mainly localized to mitochondria [1], we
decided to test whether depletion of prohibitins affected the
integrity of mitochondria. Using immunofluorescence microscopy
we observed a clear fragmentation of the mitochondrial network in
cells expressing shPHB1-3, which increased over time (Fig. 3A,B);
Expression of shPHB2-0 failed to induce a significant increase in
fragmentation of the mitochondrial network (Fig. 3A,B). In
addition, expression of shPHB1-3 resulted in a more efficient
knockdown of both prohibitins.
Amongst many other proteins, OPA1 plays a major role in the
control of mitochondrial fusion [31] and cristae integrity [32].
Since previous publications have shown that prohibitins are
necessary for stable expression of OPA1 [17,21], we analyzed the
effect of PHB1 and PHB2 depletion on the levels of mitochondrial
fusion protein OPA1. OPA1 proteins are expressed as seven splice
variants, visible as five bands (a–e) on a Western blot, attributed in
part to the fusion activity of OPA1 [33]. We observed degradation
of OPA1 in cells depleted of prohibitins, which correlated with the
efficiency of prohibitins depletion. In particular, the fusion
competent fragments a and b were lost and the small fragments
c–e increased upon PHB1 depletion for longer time periods
(Fig. 3C, D). Interestingly, in cells expressing shPHB2-0 bands a
and b remained intact, and only increases in band e were observed
(Fig Fig. 3C). The effect was specific for OPA1 since degradation
of other mitochondrial protein, including Hsp60, ATP synthase
and Tims and Toms was not observed (data not shown). These
results support a selective activity of the shPHB1-3 in mitochon-
drial fragmentation and OPA1 degradation.
From previous studies it was known that dissipation of the MMP
induces OPA1 degradation and mitochondrial fragmentation [33].
Therefore, we tested whether the pattern of OPA1 fragmentation
induced by PHB1 depletion and MMP was similar. Cells were
treated with the uncoupling reagent carbonyl cyanide m-chloro-
phenyl hydrazone (CCCP) and the OPA1 bands were detected by
immunoblot. OPA1 protein patterns were clearly different in cells
without MMP in comparison to those depleted of PHB1 (Fig. 3E).
The fusion competent fragments of OPA1 were degraded and
expression of fragments c, d and e was increased in the absence of
MMP. In prohibitin-depleted cells, expression of band d expression
was strongly decreased, whereas band b was only slightly decreased,
suggesting that different mechanisms account for the observed
effects. In a time-course experiment, we observed that CCCP causes
mitochondria fragmentation prior to OPA1 degradation (data not
shown), indicating that OPA1 degradation may be a consequence of
mitochondrial fragmentation in this case.
To test whether silencing of PHB1 induces loss of MMP, we
stained shPHB1-3 expressing cells with tetramethylrhodamine
ethyl ester perchlorate (TMRE), a cell-permeable dye that is
sequestered by active mitochondria. TMRE staining intensity was
similar in control and PHB1-depleted cells (Fig. S2A), suggesting
that the mitochondrial membrane remains intact despite frag-
mentation of mitochondria in these cells. In accordance, ATP
levels remained unchanged in cells depleted of prohibitins (Fig.
S2B). Since OPA1 degradation has also been shown to lead to
changes in cristae morphology [32], we investigated the cristae
structure of mitochondria in cells depleted of prohibitins using
Transmission Electron Microscopy (TEM). In PHB1-silenced and
control cells, cristae structure remained intact (Fig. 3F), indicative
of a normal mitochondrial physiology.
Cell- to- cell contact is inhibited in prohibitin depleted
cells
During our initial studies on the prohibitin knockdown cell lines,
we observed that the loss of prohibitin-depleted cells was
dependent on the density at which the cells were seeded in cell
culture plates. At high cell densities, the loss of knockdown cells
was reduced but not prevented (Fig. 4A). Moreover, loss of
prohibitins expression caused a change in cell morphology in
certain cancer cell lines: HeLa cells, especially when seeded at low
density tended to remain as single cells with an elongated
morphology, reminiscent of fibroblasts (Fig. 4B). A similar
phenotype was observed when HeLa cells were kept under
suspension conditions by seeding them on agarose-covered cell
culture dishes: only control cells formed colonies, while prohibitin-
silenced cells failed to form cell- to-cell contacts and colonies
(Fig. 4C).
To study cell-matrix contact formation, cells were seeded onto
plates coated with the extracellular matrix proteins fibronectin or
collagen. Adhesion of PHB1- and PHB2-depleted cells to these
matrix proteins was significantly inhibited (Fig. 4D). To further
quantify cell-matrix attachment, focal adhesion formation was
PHB Required for Proliferation
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induced by Forskolin after serum starvation. Immunofluorescence
microscopy revealed reduced spreading and formation of actin
filaments (Fig. 4E), plus a reduction in the numbers of focal
adhesions (Fig. 4E, F). These data suggest that prohibitins also play
a role in the cell-matrix interaction.
Discussion
Since the discovery of their anti-proliferative activity, prohibitins
have been implicated in multiple cellular functions [10,18,34].
However, several lines of indirect evidence, such as their overexpres-
Figure 2. Inducible expression of shRNAs targeting either PHB1 or PHB2 led to depletion of both proteins and subsequently to a
slower cell proliferation rate. (A, B) Transduction with the pLVPT lentiviral system allows doxycycline inducible shRNA expression. Within the
indicated time of induction PHB1 and PHB2 protein expression was efficiently reduced. (C) The inducible expression of either PHB1 targeted or PHB2
targeted mRNA led to a reduced expression of both proteins, as shown by Western blot. (D) BrdU incorporation analysis shows HeLa cells expressing
shPHB1-0, shPHB1-3 or shPHB2-0 for 10 days exhibit a reduced proliferation rate in comparison to cells expressing control shRNA (shLuci). (E) CFSE
intensity as measured by FACS at 0 h (1), 24 h (2), 48 h (3), 72 h (4), and 96 h (5) is higher in prohibitin knockdown cells indicating reduced dilution of
CFSE to fast replicating daughter cells. (F) CFSE intensity was gauged by FACS every 24 h for 5 days and the median of each peak was plotted against
each other. (G) Inducible expression of shRNAs resulted in the same phenotype of reduced/loss of anchorage-independent growth in PHB1 (shPHB1-
0, shPHB1-3) and PHB2 (shPHB2-0) knockdown cells as observed with the constitutive expression system.
doi:10.1371/journal.pone.0012735.g002
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Figure 3. Prohibitin knockdown led to fragmentation of the mitochondrial network without affecting cristae morphology. (A, B)
Mitochondria from prohibitin knockdown cells were stained with anti-Tom 20 and mitochondrial fragmentation was quantified using ImageJ
software. An extended induction with doxycycline led to an increased fragmentation in shPHB1-3 expressing cells. (C) Western blots showing that
prolonged doxycycline-induced shPHB1-3 expression led to a stronger prohibitin knockdown than shPHB2-0 expression, correlating with an
increasing fragmentation of the fusion competent fragments a and b of OPA1. (D) Quantification showed that the fusion competent forms were
degraded into the smaller fragments c and e. (E) Quantification of OPA1 patterning in control cells (shLuci), PHB1-depleted cells (shPHB1-3) and cells
treated with 60 mM CCCP for 80 min (CCCP) to induce loss of DYm. The OPA1 pattern in CCCP-treated cells differed from shPHB1-3 expressing cells,
as the fragments a and b were completely lost while the smaller fragments d and e were increased. (F) TEM pictures of cells with a prohibitin
knockdown induced for 10 days showed a more dense appearance of mitochondria than shLuci-expressing control cells, but the morphology of the
cristae structure was not changed.
doi:10.1371/journal.pone.0012735.g003
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sion in numerous cancer cells [35], indicated that prohibitins were not
functioning as a classical tumor suppressor. Here, we show prohibitins
are a crucial prerequisite for cancer cell proliferation and survival. We
used lentivirus-mediated shRNA expression to specifically reduce
PHB1 and PHB2 mRNA and protein levels, respectively. Using the
constitutive expression system pLL3.7, we demonstrated that, in all
Figure 4. Prohibitin knockdown led to a changed morphology in HeLa cells and to reduced cell-cell contact. (A, B) Silencing prohibitin
expression for 10 days resulted in a stretched cell morphology with the nucleus slightly raised. (A) When seeded at low density prohibitin knockdown
cells remained as single cells with minimal cell-cell contact. (B) At higher seed density, prohibitin-knockdown cells still showed an elongated
morphology but either formed clusters (shPHB1-3) or remained predominantly as single cells with reduced cell-cell contact. The proliferation rate of
prohibitin knockdown cells was also increased in comparison to cells seeded at low to normal density. (C) Preventing anchorage by seeding cells on
agar-coated tissue culture plates strongly reduced proliferation rate and colony formation in prohibitin knockdown cells, whereas control cells (shLuci
expressing cells) formed large cell clumps. (D) Prohibitin-depleted and control cells were treated with CFSE to increase fluorescence intensity and
seeded on extracellular matrix proteins collagen or fibronectin, or on BSA for 30 min. Non- adherent cells were washed off and fluorescence intensity
was measured. Prohibitin knockdown significantly reduced adhesion. (E) Doxycycline-induced cells were seeded on coverslips for 20 h followed by
serum starvation for 4 h. After treatment with 50 mM Forskolin for 20 min, brightfield images showed lamellipodia formation in control cells but not
in prohibitin- depleted cells. Furthermore, prohibitin-depleted cells showed decreased formation of focal adhesions as shown by
immunocytochemistry staining using phalloidin and anti-paxillin antibodies. (F) For the quantification of focal adhesions in control and prohibitin
knockdown cells, a-paxillin 1 stained spots were counted in 30 cells per condition.
doi:10.1371/journal.pone.0012735.g004
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tested cancer cell lines, numbers of cells, expressing a PHB1 mRNA
targeting shRNA were decreased from within a pool of transduced
and non transduced cells. Furthermore, PHB1-depleted cells were
unable to grow under anchorage-independent conditions. Our results
are in accordance with two recent studies demonstrating that RNAi-
mediated silencing of PHB1 or PHB2, respectively, leads to reduced
proliferation in primary endothelial cells and mouse embryonic
fibroblasts [17,26]. These data are in stark contrast to a previous
study showing increased proliferation in the breast cancer melanoma
cell line MCF-7 upon siRNA-mediated silencing of PHB1 [16]. It is
possible prohibitins play a different role in breast cancer cells in
comparison to other cancer cell types.
In agreement with the initial finding that the RNA of 39UTR of
PHB1 exerts cytotoxic effects on cancer cells [9,10], the expression
of a T-allelic PHB1 39UTR has been linked with an increased
susceptibility to breast cancer [11]: however, several clinical
studies have contradicted these findings [12,13]. In addition,
sequencing of the PHB1 39UTR of different cancer cell lines,
including MCF-7, revealed a higher frequency of overall sequence
variation in comparison to primary non-cancer cells rather than a
predominant expression of a specific T-allele (CS and TR,
unpublished). These findings suggest that prohibitins do play a
role in carcinogenesis, but the level at which the effect is exerted,
i.e. 39UTR RNA or protein, remains unclear: Silencing of either
PHB1 or PHB2 mRNA by RNAi resulted in reduction of the
respective 39UTR but also in a knockdown of both prohibitin
proteins. Since expression of all tested shRNAs led to a slowed
proliferation rate, this phenotype is most likely a consequence of
the loss of prohibitin proteins.
To assess the long-term effect of prohibitin depletion, we
generated HeLa cell lines with inducible shRNA expression. In
these cells PHB1 and PHB2 mRNAs were efficiently and selectively
down-regulated upon induction of the gene-specific shRNA and
prohibitin proteins were reversibly suppressed. Similar to the
constitutive silencing of PHB1 or PHB2, induction of shRNA
expression reduced the proliferation of cells and prevented colony
formation on soft agar plates, indicative of a defect in anchorage-
independent growth. These cells lines enabled us to fine-tune PHB1
and PHB2 silencing under standardized conditions and to
investigate the mechanism underlying the strong phenotype
associated with prohibitin depletion. We first analyzed the effect
of prohibitin depletion on the levels of mitochondrial fusion protein
OPA1 as previous publications have shown that prohibitins are
necessary for stable expression of OPA1 [17,21]. We could show
that OPA1 expression is dependent on the levels of prohibitins. A
slight reduction of prohibitins, seen early after induction of shRNA
production, led to a partial fragmentation of the fusion competent
OPA1 fragments a and b. At later time points of induction and
consequently stronger depletion of prohibitins, OPA1 fragmenta-
tion increased and mitochondria appeared fragmented. An
incomplete reduction of prohibitin proteins, as seen with expression
of shRNAs shPHB1-0 and shPHB2-0, only resulted in mild OPA1
fragmentation and no fragmentation of the mitochondrial network.
Further analysis revealed that even strong and long-lasting depletion
of PHB1 e.g. in cells producing shPHB1-3, did not cause the
dissipation of MMP.
To date, the effects of prohibitin loss in mammalian cells are still
unclear: Schleicher et al. [26] and Ross et al. [27] show a
reduction in MMP upon PHB1 and PHB1/2 depletion via RNAi
in primary endothelial cells and a T-cell line, respectively; in
contrast, Merkwirth and colleagues [17] demonstrated that
although PHB2 depletion in MEFs causes OPA1 fragmentation,
respiratory activity and MMP are not affected. Treatment of cells
with the ionophore CCCP resulted in the rapid loss of MMP
accompanied by a gradual and consecutive fragmentation of the
OPA1 fusion-competent protein fragment and the mitochondrial
network. Different patterns of OPA1 fragmentation were observed
in CCCP treated cells and prohibitin-depleted cells: All fusion
incompetent fragments (c–e) were upregulated upon CCCP
treatment, but not as a consequence of prohibitin reduction. In
addition, fragment d was downregulated when prohibitin levels
were reduced, but upregulated upon CCCP treatment. Thus, our
data confirm the findings of Merkwirth at al. [17], showing
downregulation of fragment d (corresponding to fragment S4) in
PHB2-depleted MEFs.
Studies in yeast have shown prohibitins interact with mAAA
protease and are important for the proper integration of
respiratory chain complex proteins [3,23]. Furthermore, rhom-
boid like protease PARL is thought to be involved in OPA1
processing [36]. Considering the fragmentation pattern of OPA1
in prohibitin knockdown cells, it seems most likely that multiple
proteases are involved in OPA1 processing and not all of them are
affected by prohibitin loss. This would be in accordance with our
observation that both mitochondrial cristae morphology and ATP
synthesis were unaffected by a loss of prohibitins.
Mitochondrial fragmentation only occurred in cell with a strong
depletion of prohibtins as we saw it upon shPHB1-3 expression.
However, this phenotype did not correlate with the observed
proliferation defect which could already be observed in cells with a
slight reduction of prohibitin levels. Here, the expression of
shPHB2-0 which only resulted in a medium knockdown of
prohibitins caused a severe proliferation defect suggesting that the
functions of prohibitins in proliferation and mitochondrial
physiology differ. What did correlate was the occurrence of the
adhesion defect and the observed reduction in proliferation. For
instance, upon expression of shPHB2-0, cells already showed a
decrease in cell-cell contact and cell-matrix formation and were
sensitive to cell density (Fig 4A). At the same time, the proliferation
rate was strongly reduced in these cells.
In prohibitin depleted cells, the ability to adhere to fibronectin is
impaired (Fig. 4D). Experiments with Forskolin, an activator of
cAMP/PKA signaling showed that prohibitin knockdown cells
also have a defect in forming lamellipodia and focal adhesions,
both being critical events for cell movement and migration [37].
These findings are in accordance with our previous work showing
siRNA-mediated silencing of PHB1 leads to a defect in cellular
migration [6,38]. Considering these results, the role of prohibitins
in regulating cell proliferation seems to be associated with
adhesion/migration signaling. Localization studies show prohibi-
tins accumulate predominantly in mitochondria. However, both
proteins belong to the SPFH domain family and are transmem-
brane proteins. Members of this family, e.g, Flotilin, are expressed
in lipid rafts. Furthermore, we [6] and others [39] have previously
isolated prohibitins from lipid rafts. It is therefore conceivable that
prohibitins play an important role at the plasma membrane, most
likely as chaperones and scaffolding proteins as in mitochondria.
Our findings clearly show that prohibitins are required for
proliferation and growth of cancer cells and regulation of cellular
homoeostasis. We could show their crucial role in cancer cell
propagation and survival while implicating an important function
in cell adhesion and cell contact formation. This leads to an overall
perception of prohibitins as chaperoning proteins not only in the
mitochondria but throughout the cell.
Supporting Information
Figure S1 Prohibitin 1 silencing leads to a decrease in cell
proliferation and anchorage dependent growth in various cancer
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cell lines. (A) PHB1 protein levels were efficiently reduced with
expression of the shRNA shPHB1-0 in HT29, IF6 and HT1080
cells. (B) FACS analysis showed that the fraction of GFP
expressing cells was reduced within nine days of transduction
from a pool of transduced cells. These include various cancer cells
as well as primary cells. (C) Transduced cancer cells expressing
control vector or prohibitin 1 targeting shRNAs were seeded in
soft agar. Only control cells grew under anchorage independent
conditions and formed colonies.
Found at: doi:10.1371/journal.pone.0012735.s001 (0.32 MB JPG)
Figure S2 Mitochondrial function is not impaired in prohibitin-
depleted cells. (A) To analyze the MMP upon prohibitin depletion,
cells were stained with 100 nM TMRE for 30 min and analyzed
by FACS. To induce a loss of MMP, cells were treated with 1 mM
CCCP for 5 min. (B) The MMP was not changed compared to
that of control cells (shLuci). Measurement of ATP levels using the
ATP Bioluminescence Assay Kit HSII (ROCHE) showed no
reduction in prohibitin-depleted cells.
Found at: doi:10.1371/journal.pone.0012735.s002 (0.11 MB JPG)
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